Parkinson's disease / editors, Melvin D. Yahr, Kenneth J. Bergmann.

Format:

Book

Conference/Event

Contributor:

Yahr, Melvin D. (Melvin David), 1917-2004.

Bergmann, Kenneth J.

International Federation of Parkinson's Disease Foundations.

Conference Name:

International Symposium on Parkinson's Disease (8th : 1985 : New York, N.Y.)

Series:

Advances in neurology ; v. 45.

Advances in neurology ; v. 45

Language:

English

Subjects (All):

Parkinson's disease--Congresses.

Parkinson's disease.

Parkinson Disease.

Medical Subjects:

Parkinson Disease.

Genre:

Kongress -- New York (NY) -- 1985.

Conference papers and proceedings.

Physical Description:

xxiii, 616 pages : illustrations ; 26 cm.

Place of Publication:

New York : Raven Press, [1987]

Contents:

Overview of morphological changes in Parkinson's disease

Biochemical pathophysiology of Parkinson's disease

Lewy body in Parkinson's disease

Transmitter receptor alterations in Parkinson's disease

Dopamine D2 receptor density in Parkinsonian brain is constant for duration of disease, age, and duration of L-DOPA therapy

Ultrastructural chemoanatomy of the basal ganglia: an overview

Dopaminergic-peptidergic interactions in extrapyramidal disorders: a review of the clinical evidence

GABA-dopamine relationship in Parkinson's disease striatum

GABA receptor agonists and extrapyramidal motor function: therapeutic implications for Parkinson's disease

Nigral and adrenal grafts in Parkinsonism: recent basic and clinical studies

Positron emission tomography in Parkinson's disease: glucose and DOPA metabolism

Regional kinetics of [11C]methylspiperone in the brain studied by positron emission tomography in patients with Parkinson's disease

MRI study on Parkinson's disease in relation to the severity of disease

Critical role of MAO inhibition in Parkinson's disease

Localization of MAO-A and MAO-B in human brain: a step in understanding the therapeutic action of L-deprenyl

Monamine oxidase, hydrogen peroxide, and Parkinson's disease

MAO type B inhibitors as adjunct to L-DOPA therapy

Toxins and Parkinson's disease: MPTP Parkinsonism in humans and animals

Tissue culture model for studying MPTP toxicity to dopamine neurons

Studies on the mechanism of the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

Characterization of [3H]MPTP binding sites

Autoradiographic distributions of neurotransmitter receptors in the human brains of Parkinson's disease and primate models of MPTP-induced Parkinsonism

Determinatin and visualization of damage to striatal dopaminergic terminals in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism by [18F]-labeled 6-fluoro-L-DOPA and positron emission tomography

Changes in the local cerebral metabolic rate for glucose in the MPTP primate model of Parkinson's disease

Ro 16-6491: a new reversible and highly selective MAO-B inhibitor protects mice from the dopaminergic neurotoxicity of MPTP

Endogenous analogs of N-methyl-4-phenyl-tetrahydropyridine: indoleamine derived tetrahydro-beta-carbolines as potential causative factors in Parkinson's disease

MPTP-induced Parkinsonism in the common marmoset: behavioral and biochemical effects

Pathology of MPTP in the marmoset.

Progressive supranuclear palsy: anatomoclinical and biochemical considerations

"Pure akinesia" and the later added supranuclear ophthalmoplegia

Juvenile onset Parkinson's disease

Effects of tyrosine administration on plasma biopterin in patients with juvenile Parkinsonism and their relatives

Biosynthesis of tetrahydrobiopterin in Parkinsonian human brain

Hereditary progressive dystonia with marked dirurnal fluctuation: clinico-pathophysioogical identification in reference to juvenile Parkinson's disease

Long-term course in Parkinson's syndrome and cerebral polypathy (Parkinson plus)

Cerebrospinal fluid arginine vasopressin in Parkinson's disease, dementia, and other degenerative disorders

Amino acid abnormalities in cerebrospinal fluid and blood serum of patients with Parkinson's disease, other heredodegenerative disorders and head injuries

Dopamine receptor function in Parkinson's disease

in vivo studies with prolactin responses

Study of platelet alpha2 -adrenoceptors in Parkinson's disease

Serum norepinephrine response to standing in patients with Parkinson's disease

Blood pressure effects of apomorphine and domperidone in Parkinsonism

Parasympathetic assessment in Parkinson's disease

Breathing in Parkinson's disease

Sleep apnea in idiopathic and postencephalitic Parkinsonism

Descriptive epidemiology of Parkinson's disease: disease distribution and hypothesis formulation

Clues from epidemiology of Parkinson's disease

Epidemiological evaluations of risk factors in Parkinson's disease

Early onset Parkinson's disease and childhood environment

Environmental and genetic factors in the etiology of Parkinson's disease

Genetics of Parkinson's disease

Family history of tremor in Parkinson's disease compared to controls and patients with idiopathic dystonia

Relationship of aging in Parkinson's disease

Visual system in Parkinson's disease

Quantitative study of "on-off" fluctuations in the ocular motor system in Parkinson's disease

Oral sensorimotor defects in patients with Parkinson's disease

Sensorimotor disturbances in Parkinson's disease: index finger test.

Relationships between pain, depression and sleep alterations in Parkinson's disease

Assessment of rest tremor in Parkinson's disease

Clinical and radiographic features of scoliosis in Parkinson's disease

Foot dystonia in Parkinson's disease: clinical phenomenology and neuropharmacology

Movement disorders in patients with coexistent neuroleptic-induced tremor and tardive dyskinesia: EMG and pharmacological study

Disturbances of two motor acts in patients with Parkinsonism and cerebellar ataxia

Postural adjustments associated with rapid voluntary arm movements in patients with Parkinson's disease

Coordination of manual postural and locomotor movements during simple goal directed motor tasks in Parkinsonian "Off" and "On" states

Cognitive impairments in Parkinson's disease

Clinical and neurochemical consequences of neuronal loss in the nucleus basalis of Meynert in Parkinson's disease and Alzheimer's disease

Dementia of Parkinson's disease

Intellectual impairment in Parkinson's disease

Psychometric findings in clinical subtypes of Parkinson's disease

Predictive factors for cognitive deterioration and dementia in Parkinson's disease

Behavioral indicators of hallucinations in levodopa-treated Parkinson's disease

Neuropsychological profile of primary Parkinsonism among Filipinos

Possible involvement of attention processes in Parkinson's disease

Familial Alzheimer's disease presenting as levopoda-responsive Parkinsonism

Depression and cognitive changes in Parkinson's disease: a review

Dexamethasone suppression test in Parkinson's disease

Mental depression in untreated Parkinson's disease of recent onset

Concept of bradyphrenia: a neuropsychiatric approach

Depression and Parkinson's disease

Parkinson's disease: progression and mortality

Parkinson's disease and long-term levopoda therapy

Sixteen-year follow-up of 100 patients begun on levodopa in 1968: emerging problems

Long-term effect of levodopa on progression of Parkinson's disease

Fluctuation in response to chronic levodopa therapy: pathogenetic and therapeutic considerations

Pharmacokinetics of L-DOPA in patients with Parkinson's disease

Pharmacokinetics of levodopa and motor fluctuations

Single-dose study of slow release preparation of levodopa and benserazide (madopar HBS) in Relationships between pain, depression and sleep alterations in Parkinson's disease

Disturbances of two motor acts in patients with Parkinsonism and cerebellar ataxia

Coordination of manual postural and locomotor movements during simple goal directed motor tasks in Parkinsonian "Off"- and "On" -states.

Cognitive impairments in Parkinson's disease

Dementia of Parkinson's disease

Sixteen-year follow-up of 100 patients begun on levodopa in 1968: emerging problems

Pharmacokinetics of L-DOPA in patients with Parkinson's disease.

Pharmacokinetics of levodopa and motor fluctuations

Single-dose study of slow release preparation of levodopa and benserazide (madopar HBS) in Parkinson's disease

Individual levodopa therapy in Parkinson's disease

long-lasting drug holiday in Parkinson's disease

Biochemical effects of chronic L-dopa treatment in rats: implications for emergence of tolerance phenomena in patients with Parkinson's disease

Current and future approaches to therapy

Development of new pharmacological approaches in Parkinson's disease

Dopamine agonists as primary treatment in Parkinson's disease

Long-term effects of bromocriptine given to de novo patients with idiopathic Parkinson's disease

Low-dose treatment in de novo patients with Parkinson's disease: a prospective study

Bromocriptine in the treatment of Parkinson's disease: a double blind study against L-dopa/carbidopa

Long-term treatment with high-dosage bromocriptine in advanced Parkinson's disease

Treatment of early morning akinesia with low-dose bromocriptine

Pergolide mesylate: four years experience in Parkinson's disease

Parrallel double-blind study of pergolide in Parkinson's disease

Double-blind controlled study of pergolide mesylate as an adjunct to sinemet in the treatment of Parkinson's disease

parenteral administration of lisuride in Parkinson's disease

Comparison of efficacy of lisuride hydrogen maleate with increased doses of levodopa in Parkinsonian patients

Terguride: partial dopamine agonist in the treatment of Parkinson's disease

Evaluation of terguride in patients with Parkinson's disease

Effect of ciladopa on Parkinson's disease: a preliminary report

Mechanism of action of L-leucyle-glycinamide and its effect on Parkinson's disease

Therapeutic experiences with an abeorphine-derivative in Parkinson's disease

Clinical effects of L-threo-3,4-dihydroxyphenylserine in cases of Parkinsonism and pure akinesia

Consequences of chronic 5-hydroxy-tryptophan in Parkinsonian instability of gait and balance and in other neurological disorders.

Notes:

Proceedings of the 8th International Symposium on Parkinson's Disease, held June 9-12, 1985, in New York City, and sponsored by the International Federation of Parkinson's Disease Foundations.

Includes bibliographical references and index.

Other Format:

Online version: Parkinson's disease.

ISBN:

088167205X

9780881672053

OCLC:

13406887